samedan logo
 
 
spacer
home > pmps > winter 2002 > improving efficiency and reducing costs - what part do information systems play?
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Improving Efficiency and Reducing Costs - What Part Do Information Systems Play?

The pharmaceutical industry isn't alone in feeling the pressure that companies across almost all markets face to drive down costs, increase profit and grow market share. But these demands are compounded by forces peculiar to pharmaceutical production. These include evolving regulatory requirements, the explosion of competition caused by the dissolution of patent protections and the relationship between drugs and peoples' health. This is a high-cost and high-risk industry. On average it costs $500 million and takes 10 to 12 years to develop a new drug, although only one in three actually yields return on investment (ROI).

Faced with such pressures, it has become imperative for pharmaceutical companies to look at ways to streamline processes and increase efficiency. This starts at the drug development process and runs right through to the manufacture and dispatch of products. Efficiency is crucial to the successful, profitable production of expanding product lines.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Geoff Parker, Commercial Director at Scimcon
Geoff Parker is Commercial Director at scientific information management consultancy Scimcon, where he is responsible for global sales and customer support. Geoff has a particular focus on data management strategy consultancy, and also enjoys a hands-on role advising clients on their information system requirements and system selection.

Before joining Scimcon in June 2000, Geoff spent two years with laboratory information system provider Thermo LabSystems. Prior to working in the lab information systems field, Geoff had a background in chemistry working as a Technical Chemist for a detergent company, after which he spent five years working for a major technology supplier.

spacer
Geoff Parker
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Qatar Airways Cargo and ECS Group celebrate one year of serving Lyon

Since its first flight on 17SEP20, the leading international cargo airline, together with ECS Group, the world’s largest integrated GSSA, has flown more than 5 million kilos out of Lyon, France
More info >>

White Papers

Outsourcing and Insourcing: How Eurofins solves the bio/pharma industry’s challenges associated with meeting drug development timelines and budgets with restricted headcounts

Eurofins BioPharma Product Testing

Pharmaceutical and biopharmaceutical companies face a significant challenge to get their drug products developed and launched quickly, all while keeping development costs down. One of the most common ways for companies to lower development costs is to manage fixed headcounts. But when the same scope of work still needs to be completed by a designated time with fewer staff members, this presents a significant challenge. So, how do bio/pharma companies solve this ever so common challenge of increasing output while decreasing headcount? There are essentially three options: temporary staffing, outsourcing, or insourcing.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement